Venture Life Group plc

Equities

VLG

GB00BFPM8908

Pharmaceuticals

Delayed London S.E. 07:20:19 2024-04-25 am EDT 5-day change 1st Jan Change
42.06 GBX +0.15% Intraday chart for Venture Life Group plc +10.77% +26.48%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Venture Life renews revolving credit facility with Santander and HSBC AN
Venture Life Group plc Renews Revolving Credit Facility with Santander UK PLC and HSBC Innovation Bank Limited CI
Jaguar Health Licenses Fda-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in Its Core Focus Area of Cancer Supportive Care CI
Venture Life to benefit from higher prices as profit surges in 2023 AN
Earnings Flash (VLG.L) VENTURE LIFE GROUP Reports FY23 Revenue GBP51.4M MT
Earnings Flash (VLG.L) VENTURE LIFE GROUP Reports FY23 EPS GBX0.68 MT
Venture Life credits success to portfolio "robustness and variety" AN
Venture Life loss widens on higher amortisation and finance costs AN
Earnings Flash (VLG.L) VENTURE LIFE GROUP Posts H1 Revenue GBP23.5M MT
Earnings Flash (VLG.L) VENTURE LIFE GROUP Reports H1 Loss GBX-1.19 MT
Venture Life Group plc Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Stocks called lower amid trouble in China AN
FTSE 100 Reaches Two-Month High Lifted by Miners, Oil-Exposed Stocks DJ
Venture Life interim revenue rises, outlook remains hopeful AN
Venture Life Group plc Reports Revenue Results for the Six Months Ended 30 June 2023 CI
Venture Life sees minor shareholder rebellion at AGM AN
FTSE 100 Closes Up 0.2% Lifted by Banks, Discretionary Sector DJ
UK Labor Market Loosening Suggests Peak Interest Rates Are Near DJ
Venture Life eyes annual performance in line with guidance AN
BOE Could Increase Pace of Quantitative Tightening, Still Cut Rates in 2024 DJ
FTSE 100 Rises Amid Optimism Over Improved US-China Relations DJ
Sterling Could Rise if UK Underlying Price Pressures Persist DJ
Venture Life Co-Founder & CCO Sharon Daly steps down AN
Venture Life Chief Commercial Officer to Depart in August MT
Sharon Daly (nee Collins) to Leave as Director of Venture Life Group plc, Effective 3 August 2023 CI
Chart Venture Life Group plc
More charts
Venture Life Group PLC is a United Kingdom-based consumer self-care company. The principal activities of the Company are the development, manufacturing, and commercialization of healthcare products, including medical devices, food supplements and cosmetics for the ageing population. The Company's product portfolio includes products, such as the UltraDEX and Dentyl oral care product ranges; the Balance Activ range in the area of women's intimate healthcare; the Lift Glucose and Glucogel product ranges for hypoglycaemia; Gelclair, Xonrid, and Pomi-T for oncology support products provide symptomatic relief for some of the side effects associated with cancer and its treatment; the Procto-eze Plus product ranges for hemorrhoids, and other Dermatology products. The Company operates through two segments: Venture Life Brands and Customer Brands. The Company's subsidiaries include Venture Life Limited, Lubatti Limited, Periproducts Limited, HL Healthcare Ltd, and Venture Life Healthcare Ltd.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.42 GBP
Average target price
0.76 GBP
Spread / Average Target
+80.95%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VLG Stock
  4. News Venture Life Group plc
  5. Venture Life Group Buys HL Healthcare; Shares Surge 19%